In the last trading session, 2.24 million shares of the Vir Biotechnology Inc (NASDAQ:VIR) were traded, and its beta was 0.49. Most recently the company’s share price was $7.03, and it changed around -$0.98 or -12.23% from the last close, which brings the market valuation of the company to $897.58M. VIR currently trades at a discount to its 52-week high of $13.09, offering almost -86.2% off that amount. The share price’s 52-week low was $7.12, which indicates that the current value has fallen by an impressive -1.28% since then. We note from Vir Biotechnology Inc’s average daily trading volume that its 10-day average is 1.15 million shares, with the 3-month average coming to 923.07K.
Vir Biotechnology Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.78. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 3 recommended VIR as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Vir Biotechnology Inc is expected to report earnings per share of -0.86 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Vir Biotechnology Inc (NASDAQ:VIR) trade information
Instantly VIR has showed a red trend with a performance of -12.23% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 9.75 on recent trading dayincreased the stock’s daily price by 27.9%. The company’s shares are currently down -30.12% year-to-date, but still down -28.77% over the last five days. On the other hand, Vir Biotechnology Inc (NASDAQ:VIR) is -7.86% down in the 30-day period. We can see from the shorts that 5.72 million shares have been sold at a short interest cover period of 7.28 day(s).
The consensus price target as assigned by Wall Street analysts is $28.19, which translates to bulls needing to increase their stock price by 75.06% from its current value. Analyst projections state that VIR is forecast to be at a low of $15 and a high of $35.
Vir Biotechnology Inc (VIR) estimates and forecasts
Vir Biotechnology Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -27.45 percent over the past six months and at a 15.90% annual growth rate that is well below the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 0.10% in revenue this quarter, and will report a decrease of -58.33% in the next quarter. The year-over-year growth rate is expected to be -20.34%, down from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 8.14M in revenue for the current quarter. 3 analysts expect Vir Biotechnology Inc to make 18.21M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 16.79M and 56.38M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -51.51%. Forecasts for the next quarter put sales growth at -67.69%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -34.12%. Vir Biotechnology Inc earnings are expected to increase by 16.32% in 2024, but the outlook is positive 7.00% per year for the next five years.
VIR Dividends
Vir Biotechnology Inc’s next quarterly earnings report is expected to be released in December.
Vir Biotechnology Inc (NASDAQ:VIR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 11.85% of Vir Biotechnology Inc shares, and 74.47% of them are in the hands of institutional investors. The stock currently has a share float of 84.48%. Vir Biotechnology Inc stock is held by 301.0 institutions, with SB INVESTMENT ADVISERS (UK) LTD being the largest institutional investor. By 2024-06-30, it held 12.3329% of the shares, which is about 16.68 million shares worth $148.49 million.
BLACKROCK INC., with 12.1482% or 16.43 million shares worth $146.26 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
